Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|30|3577-3589

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.30, 2009-10, pp. : 3577-3589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long pentraxin PTX3 as a novel treatment for fibroblast growth factor-8-mediated tumour diseases

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 773-776

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration

By Woodbury Maya   Ikezu Tsuneya  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 92-101

Springer Publishing Company

Access to resources Recommend Favorite

Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

By  

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3815-3825

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast growth factor: potential for preventing radiation damage?

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Fibroblast growth factor: First repot of heterotopic ossification: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1152, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite